The problem isn’t BRN with revenue. The problem is poor analysis by majority of BRN shareholders, myself included.
Shareholders expected revenue when their was no refined products on the market yet. It took a couple of years for them to develop and commercialise BS AND accelerator. These have only been in market for 9 months or so. BRN also didn’t have an experienced CEO, Louise only came on board reletively recent.
Shareholders need to count time from product release not float of company.
Also realise their is time In revenue cycle, from marketing, trials, to design wins, to installation and then payment. After all that. It might not show in that quarter but the next 4c.
BRN Price at posting:
16.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)